GLP1 SEMA
GLP-1 Sema is a semaglutide-based peptide studied in research models for its interaction with GLP-1 receptor signaling and metabolic regulation pathways [1,2].
This peptide is for research purposes only. Not for human consumption.
Description
GLP-1 Receptor Interaction
GLP-1 receptor agonists are examined for their role in glucose-dependent signaling and endocrine pathway modulation [1]. Semaglutide-based constructs allow detailed analysis of receptor affinity and signaling duration.
Metabolic Pathway Research
Studies explore GLP-1 signaling in relation to insulin secretion pathways, appetite regulation markers, and energy balance mechanisms [2]. These investigations focus on pathway behavior rather than outcomes.
Structural Optimization
Semaglutide modifications enhance peptide stability and receptor engagement, supporting comparative signaling analysis across incretin analogs [1].
Key Specs
- Peptide class: GLP-1 analog
- Research context: incretin receptor signaling
- References: PubChem, PubMed [1,2]
Referenced Citations
- PubChem, Semaglutide: https://pubchem.ncbi.nlm.nih.gov/compound/Semaglutide
- PubMed, GLP-1 receptor signaling: https://pubmed.ncbi.nlm.nih.gov/11206657/
Additional information
| Size | 5MG, 10MG, 20MG |
|---|
GLP-1 Receptor Interaction
GLP-1 receptor agonists are examined for their role in glucose-dependent signaling and endocrine pathway modulation [1]. Semaglutide-based constructs allow detailed analysis of receptor affinity and signaling duration.
Metabolic Pathway Research
Studies explore GLP-1 signaling in relation to insulin secretion pathways, appetite regulation markers, and energy balance mechanisms [2]. These investigations focus on pathway behavior rather than outcomes.
Structural Optimization
Semaglutide modifications enhance peptide stability and receptor engagement, supporting comparative signaling analysis across incretin analogs [1].
Key Specs
- Peptide class: GLP-1 analog
- Research context: incretin receptor signaling
- References: PubChem, PubMed [1,2]
Referenced Citations
- PubChem, Semaglutide: https://pubchem.ncbi.nlm.nih.gov/compound/Semaglutide
- PubMed, GLP-1 receptor signaling: https://pubmed.ncbi.nlm.nih.gov/11206657/
Reviews
There are no reviews yet.